Last 34.55 INR
Change Today +1.20 / 3.60%
Volume 31.8K
As of 1:03 AM 12/29/14 All times are local (Market data is delayed by at least 15 minutes).

jagsonpal pharmaceuticals (JGPH) Snapshot

Open
33.05
Previous Close
33.35
Day High
36.50
Day Low
33.05
52 Week High
12/8/14 - 46.85
52 Week Low
03/6/14 - 8.70
Market Cap
905.1M
Average Volume 10 Days
122.1K
EPS TTM
2.85
Shares Outstanding
26.2M
EX-Date
09/25/14
P/E TM
12.1x
Dividend
0.50
Dividend Yield
1.45%
Current Stock Chart for JAGSONPAL PHARMACEUTICALS (JGPH)

Related News

No related news articles were found.

jagsonpal pharmaceuticals (JGPH) Related Businessweek News

No Related Businessweek News Found

jagsonpal pharmaceuticals (JGPH) Details

Jagsonpal Pharmaceuticals Limited develops and manufactures active pharmaceutical ingredients and formulations worldwide. The company’s active pharmaceutical ingredients (APIs) include allylestrenol, dextropropoxyphene HCL, dextropropoxyphene napsylate, disulfiram, thiopental sodium, thiopental acid, tolnaftate, and sildenafil citrate, as well as metformin HCL, BP, USP, and EP. It offers products for various therapeutic categories, such as anabolic steroids, analgesics, anesthetics, anti-allergic, anti-asthamatics, anti-cholinergic agents, anti-convulsants, anti-diabetics, anti-diarrhoeals, anti-emetics, anti-epileptics, anti-fungal agents, anti-gout agents, anti-inflammatory agents, anti-malarials, anti-nauseants, anti-protozoals, anti-pyretic, anti-rheumatic drugs, anti-spasmodic agents, and anti-septic agents. The company also offers anti-tubercular drugs, anti-ulcerants, anxiolytics, cardiovascular drugs, corticosteroids, cough syrups, diuretics, drugs for alcohol dependence, GI anti-infectives, haematinics, imaging agents, laxatives, male/female hormones, multivitamins, nutraceuticals, ophthalmic lubricants, oral rehydrating salts, sedative-hypnotics, softgels, systemic anti-infectives, throat pain spray, tonics, and uterine stimulants. Jagsonpal Pharmaceuticals Limited sells its products under the Lycored, Metadec, Maintane, Metabol, Doxypal DR, Parvon, and Indocap SR brand names. The company was founded in 1964 and is based in New Delhi, India.

Founded in 1964

jagsonpal pharmaceuticals (JGPH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jagsonpal pharmaceuticals (JGPH) Key Developments

JAGSONPAL Pharmaceuticals Ltd Reports Unaudited Earnings Results for the Second Quarter and Half Year Ended September 30, 2014

JAGSONPAL Pharmaceuticals Ltd. reported unaudited earnings results for the second quarter and half year ended September 30, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 329.606 million against INR 367.897 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 17.523 million against INR 12.142 million a year ago. Profit from ordinary activities before tax was INR 6.972 million against INR 0.959 million a year ago. Net profit for the period was INR 3.672 million against INR 0.059 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.14 against INR 0.00 a year ago. For the half year, the company reported net sales/income from operations (net of excise duty) of INR 668.737 million against INR 748.685 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 39.371 million against INR 25.726 million a year ago. Profit from ordinary activities before tax was INR 17.070 million against INR 1.045 million a year ago. Net profit for the period was INR 10.770 million against INR 0.095 million a year ago. Basic and diluted earnings per share (after extraordinary items) were INR 0.41 against INR 0.00 a year ago.

JAGSONPAL Pharmaceuticals Ltd to Report Q2, 2015 Results on Nov 14, 2014

JAGSONPAL Pharmaceuticals Ltd announced that they will report Q2, 2015 results on Nov 14, 2014

JAGSONPAL Pharmaceuticals Ltd, Board Meeting, Nov 14, 2014

JAGSONPAL Pharmaceuticals Ltd, Board Meeting, Nov 14, 2014. Agenda: To consider the un-audited financial results (provisional) of the company for the quarter ended September 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JGPH:IN 34.55 INR +1.20

JGPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JGPH.
View Industry Companies
 

Industry Analysis

JGPH

Industry Average

Valuation JGPH Industry Range
Price/Earnings 26.6x
Price/Sales 0.6x
Price/Book 0.9x
Price/Cash Flow 14.0x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAGSONPAL PHARMACEUTICALS, please visit www.jagsonpal.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.